Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.

Dallavalle C, Albino D, Civenni G, Merulla J, Ostano P, Mello-Grand M, Rossi S, Losa M, D'Ambrosio G, Sessa F, Thalmann GN, Garcia-Escudero R, Zitella A, Chiorino G, Catapano CV, Carbone GM.

J Clin Invest. 2016 Dec 1;126(12):4585-4602. doi: 10.1172/JCI86505. Epub 2016 Nov 7.

2.

Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study.

Oderda M, Faletti R, Battisti G, Dalmasso E, Falcone M, Marra G, Palazzetti A, Zitella A, Bergamasco L, Gandini G, Gontero P.

Urol Int. 2016;97(2):230-7. doi: 10.1159/000445524. Epub 2016 Jun 4.

PMID:
27256369
3.

A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?

Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P.

Prostate. 2015 Aug 1;75(11):1177-86. doi: 10.1002/pros.22999. Epub 2015 Apr 20.

PMID:
25893930
4.

Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.

Russo A, Modica F, Guarrera S, Fiorito G, Pardini B, Viberti C, Allione A, Critelli R, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Frea B, Vineis P, Sacerdote C, Matullo G.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2439-46. doi: 10.1158/1055-9965.EPI-14-0228. Epub 2014 Sep 18.

5.

DKK-1 in prostate cancer diagnosis and follow up.

D'Amelio P, Roato I, Oderda M, Soria F, Zitella A, Ferracini R, Mengozzi G, Gontero P, Isaia GC.

BMC Clin Pathol. 2014 Mar 21;14(1):11. doi: 10.1186/1472-6890-14-11.

6.

Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?

Gontero P, Gillo A, Fiorito C, Oderda M, Pacchioni D, Casetta G, Peraldo F, Zitella A, Tizzani A, Ricceri F.

Urol Int. 2014;92(2):136-42. doi: 10.1159/000351961. Epub 2013 Sep 25.

PMID:
24080613
7.

Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.

Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Vineis P, Matullo G.

Int J Cancer. 2013 Oct 15;133(8):2004-9. doi: 10.1002/ijc.28186. Epub 2013 Apr 25.

8.

Prognostic factors including Ki-67 and p53 in Bacillus Calmette-Guérin-treated non-muscle-invasive bladder cancer: a prospective study.

Oderda M, Ricceri F, Pisano F, Fiorito C, Gurioli A, Casetta G, Zitella A, Pacchioni D, Gontero P.

Urol Int. 2013;90(2):184-90. doi: 10.1159/000343431. Epub 2013 Jan 17.

PMID:
23328160
9.

Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis.

Oderda M, Cattaneo E, Soria F, Barreca A, Chiusa L, Morelli B, Zitella A, Gontero P.

ScientificWorldJournal. 2011;11:1548-53. doi: 10.1100/tsw.2011.144.. Epub 2011 Aug 16.

10.

[Alternative tests to PSA for prostate cancer diagnosis].

Defilippi E, Zitella A, Tizzani A.

Urologia. 2011 Apr-Jun;78(2):75-81. doi: 10.5301/RU.2011.7973. Review. Italian.

PMID:
21553390
11.

Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series.

Oderda M, Zitella A, Richiardi L, Tizzani A, Gontero P.

Arch Ital Urol Androl. 2010 Dec;82(4):135-8.

PMID:
21341547
12.

The hidden life of NAD+-consuming ectoenzymes in the endocrine system.

Malavasi F, Deaglio S, Zaccarello G, Horenstein AL, Chillemi A, Audrito V, Serra S, Gandione M, Zitella A, Tizzani A.

J Mol Endocrinol. 2010 Oct;45(4):183-91. doi: 10.1677/JME-10-0082. Epub 2010 Jul 21. Review.

PMID:
20660167
13.

Ablative therapies in the treatment of small renal tumors: how far from standard of care?

Gontero P, Joniau S, Zitella A, Tailly T, Tizzani A, Van Poppel H, Kirkali Z.

Urol Oncol. 2010 May-Jun;28(3):251-9. doi: 10.1016/j.urolonc.2009.06.008. Epub 2009 Nov 7. Review.

PMID:
19897385
14.

Fatal haematuria in a patient with an orthotopic neobladder and chronic liver failure.

Oderda M, Mondino P, Lucca I, Fiorito C, Gillo A, Zitella A, Greco A, Tizzani A, Gontero P.

Urol Int. 2009;83(3):368-9. doi: 10.1159/000241686. Epub 2009 Oct 13.

PMID:
19829044
15.

Multipathogenetic origin of a pelvic mass.

Oderda M, Mondino P, Zitella A, Vigna D, Fiorito C, Pacchioni D, Tizzani A, Gontero P.

Eur Urol. 2009 May;55(5):1224-8. doi: 10.1016/j.eururo.2008.12.023. Epub 2008 Dec 31.

PMID:
19131154
16.

[Update on epidemiology and risk factors of prostate cancer].

Oderda M, Mondino P, Zitella A, Gontero P, Tizzani A.

Urologia. 2008 Jul-Sep;75(3):143-8. Italian.

PMID:
21086342
17.

Re: Lack of association between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and risk of renal cell carcinoma.

Zitella A, Gontero P.

Int Braz J Urol. 2007 Nov-Dec;33(6):838-9. No abstract available.

18.

[Neuroendocrine bladder cancer: oncological emergency?].

Fiorito C, Lucca I, Oderda M, Mondino P, Berta G, Cattaneo EA, Valentino F, Zitella A, Pacchioni D.

Urologia. 2008 Jan-Mar;75(1):57-61. Italian.

PMID:
21086378
19.

Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.

Chiappino I, Destefanis P, Addeo A, Galetto A, Cucchiarale G, Munoz F, Zitella A, Ferrando U, Fontana D, Ricardi U, Tizzani A, Bertetto O.

Am J Clin Oncol. 2007 Jun;30(3):234-8.

PMID:
17551298
20.

[Leiomyosarcoma of the vessels of the renal ileus : a case report].

Ghignone GP, Piana P, Greco A, Zitella A, De Libero A, Petraz M, Tizzani A.

Minerva Urol Nefrol. 2006 Sep;58(3):174. Italian. No abstract available.

PMID:
17124490
21.

[Adenocarcinoma of the scrotum: a case report].

Ghignone GP, Petraz M, Casetta G, Greco A, Zitella A, Fiorio M, Buffa Di Perrero E, Tizzani A.

Minerva Urol Nefrol. 2006 Sep;58(3):173-4. Italian. No abstract available.

PMID:
17124489
22.

Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia.

Zitella A, Berruti A, Destefanis P, Mengozzi G, Torta M, Ceruti C, Casetta G, Mosca A, Greco A, Rolle L, Aimo G, Aroasio E, Tizzani A, Dogliotti L, Fontana D; Gruppo Oncologico Urologico Piemontese (GOUP).

Clin Chim Acta. 2007 Feb;377(1-2):103-7. Epub 2006 Sep 5.

PMID:
17034778
23.
25.

Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC).

Gontero P, Casetta G, Maso G, Sogni F, Pretti G, Zitella A, Frea B, Tizzani A.

Eur Urol. 2004 Sep;46(3):339-43.

PMID:
15306105
26.

Clear cell sarcoma of the kidney with invasion of the inferior vena cava.

Rosso D, Ghignone GP, Bernardi D, Zitella A, Casetta G, De Zan A, Tizzani A.

Urol Int. 2003;70(3):251-2. Review.

PMID:
12660471
27.

[Communication between urologist and pathologist. Proposal for the standardization of histological tests requests for neoplasms].

Casetta G, Moiso A, Zitella A, Tizzani A.

Minerva Urol Nefrol. 2001 Dec;53(4):221-9. Italian.

PMID:
11753250
28.

Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events.

Volante M, Tizzani A, Casetta G, Zitella A, Pacchioni D, Bussolati G.

Hum Pathol. 2001 May;32(5):468-74.

PMID:
11381363
29.

[Large calcifications on double J ureteral endoprosthesis "forgotten" in situ. Report of a clinical case].

De Luca S, Milan GL, Zitella A, Castelli E, Greco A, Tizzani A.

Minerva Urol Nefrol. 2000 Dec;52(4):211-4. Italian.

PMID:
11315332
30.

Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.

Priolo G, Gontero P, Martinasso G, Mengozzi G, Formiconi A, Pelucelli G, Zitella A, Casetta G, Viberti L, Aimo G, Tizzani A.

Clin Chim Acta. 2001 Mar;305(1-2):47-53.

PMID:
11249922
31.

BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.

Casetta G, Gontero P, Zitella A, Pelucelli G, Formiconi A, Priolo G, Martinasso G, Mengozzi G, Aimo G, Viberti L, Tizzani A.

Urol Int. 2000;65(2):100-5.

PMID:
11025432
32.

Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.

Gontero P, Casetta G, Zitella A, Ballario R, Pacchioni D, Magnani C, Muir GH, Tizzani A.

Eur Urol. 2000 Sep;38(3):287-96.

PMID:
10940702
33.

[Rare renal tumors (neoplasms other than conventional renal cell carcinoma). Clinico-pathologic aspects and review of the literature].

Casetta G, De Zan A, Moiso A, Zitella A, Viberti L, Tizzani A.

Minerva Urol Nefrol. 1999 Sep;51(3):149-56. Italian.

PMID:
10638178
34.

Recurrent calcium oxalate urolithiasis in a man with familial periodic paralysis and hypokalemia.

Zitella A, Moiso A, De Zan A, Casetta G, Piana P, Tizzani A.

J Urol. 1999 Jun;161(6):1899. No abstract available.

PMID:
10332462

Supplemental Content

Loading ...
Support Center